Elisabetta Leo
Senior Director, Early Development Asset Lead Ipsen Pharma
Multidisciplinary cancer biologist, drug discoverer and developer, translational researcher. Team and project senior director, research and analytical skills including demonstrated ability to generate novel hypotheses that led to identification of multiple therapeutic targets in several cancer indications. Experienced in leading all aspects of the drug discovery process, from early discovery and development, to drug launch.
Experienced in elaborate therapeutic hypothesis to inform translational plans and patient stratification strategy, with particular focus on expanding the therapeutic potentials of drugs (enhance efficacy and reduce toxicity). Passionate about connecting investigators with different expertise and delivering on project milestones.
Seminars
- Emphasising the importance of pursuing novel targets amongst a crowded clinical landscape
- Contextualising learnings from progressing a novel target ADC to clinical trials to develop ADCs with meaningful patient impact
- Incorporating learnings from historical profiles of adjacent target ADC: What are the indications of promising performance?